What is LipoCoat?
LipoCoat operates at the intersection of material science and clinical application, specializing in bio-inspired coatings that fundamentally enhance the safety and efficacy of medical devices. By mimicking the natural phospholipid bilayer of human cell membranes, the company's technology provides critical anti-fouling and non-thrombogenic properties. This innovation is pivotal for the health and nutrition sectors, where surface-level interactions dictate the success of long-term medical implants and diagnostic tools. Recognized as a leader in the European biotech landscape, LipoCoat maintains a robust pipeline of discovery and clinical-stage programs, positioning itself as a critical partner for global medical device manufacturers seeking to improve patient outcomes through superior surface solutions.
How much funding has LipoCoat raised?
LipoCoat has raised a total of $1.6M across 1 funding round:
Other Financing Round
$1.6M
Other Financing Round (2020): $1.6M with participation from Enschede and Rabo Investments
Key Investors in LipoCoat
Rabo Investments
Rabo Investments is the investment arm of Rabobank, dedicated to supporting the mission of Growing A Better World Together. The company provides equity capital to established and transformative companies, as well as top-tier funds, primarily in the Food and Agri and Sustainability sectors.
Enschede
A regional investment entity focused on fostering local innovation and supporting the growth of high-potential technology startups within the Dutch ecosystem.
What's next for LipoCoat?
With the recent infusion of capital, LipoCoat is poised to transition from its current development phase toward broader commercialization and expanded clinical validation. The strategic roadmap focuses on scaling its manufacturing capabilities and deepening its footprint in the drug discovery sector. By leveraging its unique surface technology, the company aims to address unmet needs in biocompatibility, potentially setting a new industry standard for medical device integration. As the firm advances its pipeline, the focus will remain on securing regulatory milestones and fostering partnerships that translate its scientific breakthroughs into tangible, market-ready health solutions.
See full LipoCoat company page
